| Future Health Pharma GmbH - Actonel 35 mg, magensaftresistente Tabletten | | 69144 | | 01 | | Actonel 35 mg | | magensaftresistente Tabletten | | M05BA07 | | Risedronsäure | | 14.02.2024 | | |
| | Composition | | natrii risedronas 35.0 mg corresp. risedronas 32.48 mg, cellulosum microcristallinum silicificatum, dinatrii edetas, carboxymethylamylum natricum A, acidum stearicum, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, talcum, E 172 (flavum), simeticonum, polysorbatum 80, pro compresso obducto corresp. natrium 16.64 mg. | | Packungsbestandteile | | Comprimés résistants au suc gastrique | | | | Principe actif | Concentr. |
|---|
| Sodium Risedronate | 35 mg correspond Risedronas 32.48 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Acidi Methacrylici | | Überzug | | Acidum Stearicum | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum Silicificatum | | | | Dinatrii Edetas | | | | E 172 | | color. | | Ethylis Acrylatis Polymerisatum Dispersio | 30 | | | Magnesii Stearas | | | | Per Centum | | | | Polysorbatum 80 | | | | Pro Compresso Obducto | | | | Simeticone | | | | Talcum | | | | Triethylis Citras | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 4 | DDP | DDP | B | | Non | | 002 | 12 | DDP | DDP | B | | Non |
|
|
